Nuclear Medicine Therapeutics Market Report

Global and China Nuclear Medicine Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 15, 2022
  • PAGES：204
  • REPORT CODE：GMM1375941
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Nuclear Medicine Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Siemens Healthcare (PETNET Solutions)

    • Lantheus Medical Imaging

    • NTP Radioisotopes

    • IBA Group

    • Triad Isotopes

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Alpha Emitters

    • Beta Emitters

    • Brachytherapy

    Application:

    • Application 1

    • Application 2

    • Application 3

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Nuclear Medicine Therapeutics Industry Overview

      • 1.1.1 Nuclear Medicine Therapeutics Market Scope and Market Segments

      • 1.1.2 Nuclear Medicine Therapeutics Industry Characteristics

      • 1.1.3 Global and China Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Nuclear Medicine Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Nuclear Medicine Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Alpha Emitters

      • 1.2.2 Beta Emitters

      • 1.2.3 Brachytherapy

    • 1.3 Global Nuclear Medicine Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Application 1

      • 1.3.2 Application 2

      • 1.3.3 Application 3

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Nuclear Medicine Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Nuclear Medicine Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Nuclear Medicine Therapeutics Industry PEST Analysis

    • 2.3 Nuclear Medicine Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Nuclear Medicine Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Nuclear Medicine Therapeutics Industry

    Chapter 3 Global and China Nuclear Medicine Therapeutics Market, by Manufacturer

    • 3.1 Global and China Nuclear Medicine Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Nuclear Medicine Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Nuclear Medicine Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Nuclear Medicine Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Nuclear Medicine Therapeutics Market Top 3 Players

    Chapter 4 Global and China Nuclear Medicine Therapeutics Market, by Type (2017-2028)

    • 4.1 Nuclear Medicine Therapeutics Market Trend, by Type

    • 4.2 Global Nuclear Medicine Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Nuclear Medicine Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Nuclear Medicine Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Nuclear Medicine Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Nuclear Medicine Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Nuclear Medicine Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Nuclear Medicine Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Nuclear Medicine Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Nuclear Medicine Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Nuclear Medicine Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Nuclear Medicine Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Nuclear Medicine Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Nuclear Medicine Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Nuclear Medicine Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Nuclear Medicine Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Nuclear Medicine Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Nuclear Medicine Therapeutics Market Analysis

    • 7.1 North America Nuclear Medicine Therapeutics Market, by Type

    • 7.2 North America Nuclear Medicine Therapeutics Market, by Application

    • 7.3 North America Nuclear Medicine Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Nuclear Medicine Therapeutics Market Analysis

    • 8.1 Europe Nuclear Medicine Therapeutics Market, by Type

    • 8.2 Europe Nuclear Medicine Therapeutics Market, by Application

    • 8.3 Europe Nuclear Medicine Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Nuclear Medicine Therapeutics Market Analysis

    • 9.1 APAC Nuclear Medicine Therapeutics Market, by Type

    • 9.2 APAC Nuclear Medicine Therapeutics Market, by Application

    • 9.3 APAC Nuclear Medicine Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Nuclear Medicine Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Nuclear Medicine Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Nuclear Medicine Therapeutics Company Profiles

      • 11.1 Siemens Healthcare (PETNET Solutions)

        • 11.1.1 Siemens Healthcare (PETNET Solutions) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Lantheus Medical Imaging

        • 11.2.1 Lantheus Medical Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Lantheus Medical Imaging Nuclear Medicine Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 NTP Radioisotopes

        • 11.3.1 NTP Radioisotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 NTP Radioisotopes Nuclear Medicine Therapeutics Product Profiles, Application and Specification

        • 11.3.3 NTP Radioisotopes Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 IBA Group

        • 11.4.1 IBA Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 IBA Group Nuclear Medicine Therapeutics Product Profiles, Application and Specification

        • 11.4.3 IBA Group Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Triad Isotopes

        • 11.5.1 Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Triad Isotopes Nuclear Medicine Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Triad Isotopes Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Nuclear Medicine Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Nuclear Medicine Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Nuclear Medicine Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Alpha Emitters (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Beta Emitters (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Brachytherapy (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 1 (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 2 (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Growth Rate of Application 3 (2017-2028)

    • Figure North America Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Nuclear Medicine Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Nuclear Medicine Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Nuclear Medicine Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Price Trend, by Type (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Value, by Type (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Value, by Application (2017-2028)

    • Table China Nuclear Medicine Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Nuclear Medicine Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Siemens Healthcare (PETNET Solutions) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siemens Healthcare (PETNET Solutions) Product Profiles, Application and Specification

    • Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lantheus Medical Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lantheus Medical Imaging Product Profiles, Application and Specification

    • Table Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NTP Radioisotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NTP Radioisotopes Product Profiles, Application and Specification

    • Table NTP Radioisotopes Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table IBA Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table IBA Group Product Profiles, Application and Specification

    • Table IBA Group Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Triad Isotopes Product Profiles, Application and Specification

    • Table Triad Isotopes Nuclear Medicine Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US